
In a phase 2b trial involving 129 patients with acute cervical spinal cord injury, intrathecal NG101 showed no significant improvement in upper extremity motor score (UEMS) at 6 months compared to placebo. Adverse events were similar across groups, with no treatment-related fatalities. Post-hoc analyses indicated potential benefits in motor-incomplete injuries, warranting further study.
Like
Save
Share